(5-bromo-thiazol-2-yl)-(4-methoxy-phenyl)-amine | 63615-97-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (5-bromo-thiazol-2-yl)-(4-methoxy-phenyl)-amine
• 英文别名: 5-bromo-N-(4-methoxyphenyl)-1,3-thiazol-2-amine
• CAS: 63615-97-4
• 化学式: C₁₀H₉BrN₂OS
• 分子量: 285.164
• InChiKey: SVYOYUOJJWKYDW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  62.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (5-bromo-thiazol-2-yl)-(4-methoxy-phenyl)-amine 、 乙二醇单钠盐 生成 (3aS,7aR)-N-(4-methoxyphenyl)-3a,5,6,7a-tetrahydro-[1,4]dioxino[2,3-d][1,3]thiazol-2-amine
  参考文献：
  名称：

  FORLANI L.; MEDICI A.; RICCI M.; TODESCO P. E., SYNTHESIS , 1977, NO 5, 320-322

  摘要：

  DOI：
• 作为产物：
  描述：

  对甲氧基苯基硫脲 在 溴 作用下， 以 溶剂黄146 为溶剂， 生成 (5-bromo-thiazol-2-yl)-(4-methoxy-phenyl)-amine
  参考文献：
  名称：

  Reaction of 2-Amino-5-bromo-1,3-thiazoles with Sodium 2-Hydroxyethoxide; Preparation of 2-Amino-3a,5,6,7a-tetrahydro[1,3]thiazolo[1,4]dioxins

  摘要：

  DOI：

  10.1055/s-1977-24379

文献信息

• [EN] THIAZOLE AND PYRAZOLE DERIVATIVES AS FLT-3 KINASE INHIBITORS<br/>[FR] DERIVES DE THIAZOLE ET DE PYRAZOLE EN TANT QU'INHIBITEURS DE LA KINASE FLT-3
  申请人：NOVARTIS AG

  公开号：WO2005047273A1

  公开（公告）日：2005-05-26

  The invention relates to thiazole and pyrazole derivatives of formula (I) wherein Q is S and X is C, or Q is CH and X is N; R1 is unsubtituted or substituted phenyl; and R2 is unsubstituted or substituted aryl or heteroaryl; oa a salt of the said compounds, and to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumour disease, in particular such diseases which respond to an inhibition of the FIt-3 kinase.

  该发明涉及公式(I)的噻唑和吡唑衍生物，其中Q为S且X为C，或者Q为CH且X为N；R1为未取代或取代的苯基；R2为未取代或取代的芳基或杂环芳基；或者该化合物的盐；以及其制备方法，包括含有这种衍生物的药物组合物，以及利用这种衍生物制备用于治疗增殖性疾病，如肿瘤疾病，特别是对FIt-3激酶抑制有响应的疾病的药物组合物。
• 5-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors
  申请人：Wan Yongqin

  公开号：US20080227783A1

  公开（公告）日：2008-09-18

  The invention provides 5-substituted thiazol-2-yl amino compounds of Formula (I): pharmaceutical compositions comprising such compounds and the use of such compounds for the treatment or prevention of diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of Ab 1, Aurora-A, Ber-Ab1, Bmx, CDKI/cyclinB, CHK2, Fes, FGFR3, Flt3, GSK3β, JNK1α1, Lck, MKK4 and TrkB kinases.

  本发明提供了式(I)的5-取代噻唑-2-基氨基化合物，以及包含这种化合物的制药组合物，并将这种化合物用于治疗或预防与异常或失调的激酶活性相关的疾病或障碍，特别是涉及Ab 1、Aurora-A、Ber-Ab1、Bmx、CDKI/cyclinB、CHK2、Fes、FGFR3、Flt3、GSK3β、JNK1α1、Lck、MKK4和TrkB激酶异常激活的疾病或障碍。
• Thiazole and pyrazole derivatives as flt-3 kinase inhibitors
  申请人：Bold Guido

  公开号：US20070167449A1

  公开（公告）日：2007-07-19

  The invention relates to thiazole and pyrazole derivatives of formula (I) wherein Q is S and X is C, or Q is CH and X is N; R 1 is unsubstituted or substituted phenyl; and R 2 is unsubstituted or substituted aryl or heteroaryl; or a salt of the said compounds, and to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumour disease, in particular such diseases which respond to an inhibition of the Flt-3 kinase.

  本发明涉及式(I)的噻唑和吡唑衍生物，其中Q为S且X为C，或者Q为CH且X为N；R1为未取代或取代的苯基；R2为未取代或取代的芳基或杂环基；或者上述化合物的盐，以及制备这些化合物的方法，包括含有这些衍生物的药物组合物，以及使用这些衍生物制备用于治疗增殖性疾病的药物组合物，如肿瘤疾病，特别是对抑制Flt-3激酶有反应的这种疾病。
• Thiazole and pyrazole derivatives as Flt-3 kinase inhibitors
  申请人：Novartis AG

  公开号：US07795288B2

  公开（公告）日：2010-09-14

  The invention relates to thiazole and pyrazole derivatives of formula (I) wherein Q is S and X is C, or Q is CH and X is N; R1 is unsubstituted or substituted phenyl; and R2 is unsubstituted or substituted aryl or heteroaryl; or a salt of the said compounds, and to processes for the preparation thereof, to pharmaceutical compositions comprising such derivatives and to the use of such derivatives for the preparation of pharmaceutical compositions for the treatment especially of a proliferative disease, such as a tumour disease, in particular such diseases which respond to an inhibition of the Flt-3 kinase.

  本发明涉及式（I）的噻唑和吡唑衍生物，其中Q为S且X为C，或Q为CH且X为N；R1为未取代或取代的苯基；R2为未取代或取代的芳基或杂环基；或者该化合物的盐，以及其制备方法，包括含有这种衍生物的制药组合物，以及使用这种衍生物制备用于治疗增生性疾病，如肿瘤疾病，特别是对抑制Flt-3激酶有反应的这种疾病的制药组合物的用途。
• THIAZOLE AND PYRAZOLE DERIVATIVES AS FLT-3 KINASE INHIBITORS
  申请人：Novartis AG

  公开号：EP1687285A1

  公开（公告）日：2006-08-09